Lydian Announces US$109 Million Proceeds From Closing of Previously Announced Private Placements and Exchange of Subscription Receipts
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia